AI assistant
NEXSEN LIMITED — Major Shareholding Notification 2026
Feb 26, 2026
65466_rns_2026-02-26_de7eb15f-7f6f-42b6-85c7-d7ac63e36153.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
ASX Release | 27 February 2026
==> picture [109 x 61] intentionally omitted <==
==> picture [378 x 18] intentionally omitted <==
Nexsen Limited (ASX:NXN) (“Nexsen” or the “Company”) provides the following Notice of Change of Interests of Substantial Holder in relation to itself. The disclosure requirement arises from the release of 14,200,000 Fully Paid Ordinary Shares from ASX-imposed mandatory escrow this week.
The securities released this week were held by pre-IPO investors in the Company.
==> picture [25 x 8] intentionally omitted <==
ASX release authorised by the Managing Director.
==> picture [187 x 11] intentionally omitted <==
Corporate Enquiries Company Secretary Nexsen Limited Reign Advisory e: [email protected] e: [email protected] w: nexsen.bio p: + 61 2 9174 5388
Suite 1005, 4 Bridge Street Sydney NSW 2000
Scan the QR code to join Nexsen’s Investor Centre or visit https://investors.nexsen.bio
==> picture [61 x 60] intentionally omitted <==
==> picture [141 x 12] intentionally omitted <==
==> picture [26 x 12] intentionally omitted <==
Nexsen is developing a suite of rapid point-of-care diagnostics that deliver lab-grade results for conditions that have traditionally relied on delayed lab testing. The company focuses on areas of significant unmet clinical need, where faster answers can improve patient outcomes and reduce pressure on healthcare systems.
Nexsen’s lead diagnostic is the GBS Rapid Sensor, a rapid point-of-care diagnostic for detecting Group B Streptococcus, addressing a critical unmet need in maternal health. The company is also developing rapid kidney function tests for Acute Kidney Injury and Chronic Kidney Disease, two conditions that affect more than 850 million people globally and remain underserved by slow, lab-based diagnostics.
With further diagnostics in development across human health, ag-tech and biosecurity, Nexsen aims to become a global leader in rapid point-of-care diagnostics, delivering on its mission to ensure every person benefits from a Nexsen test at some point in their life.
==> picture [596 x 54] intentionally omitted <==
----- Start of picture text -----
Nexsen Limited nexsen.bio
ASX:NXN ACN 655 182 497
----- End of picture text -----
604 page 1/2
15 July 2001
Form 604
Corporations Act 2001 Section 671B
Notice of change of interests of substantial holder
To Company Name/Scheme NEXSEN LIMITED (ASX:NXN) ACN/ARSN 655 182 497
1. Details of substantial holder(1)
Name NEXSEN LIMITED (ASX:NXN) and its controlled entities
ACN/ARSN (if applicable) 655 182 497
There was a change in the interests of the substantial holder on 25/02/2026 The previous notice was given to the company on 06/02/2026 The previous notice was dated 06/02/2026
2. Previous and present voting power
The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows:
| Class of securities (4) | Previous notice | Previous notice | Present notice | Present notice |
|---|---|---|---|---|
| Person’s votes | Voting power (5) | Person’s votes | Voting power (5) | |
| Fully Paid Ordinary Shares (FPO) | 121,630,104 | 60.7% |
107,430,104 |
53.7% |
3. Changes in relevant interests
Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company are as follows:
| Date of change |
Person whose relevant interest changed |
Nature of change (6) | Consideration given in relation to change (7) |
Class and number of securities affected |
Person’s votes affected |
|---|---|---|---|---|---|
| 25/02/2026 | Nexsen Limited | Ceasing of restrictions on the disposal of shares under mandatory escrow arrangements imposed by the Company in accordance with the ASX Listing Rules |
N/A |
14,200,000 FPO | 14,200,000 |
4. Present relevant interests
Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows:
| Holder of relevant interest |
Registered holder of securities |
Person entitled to be registered as holder(8) |
Nature of relevant interest (6) | Class and number of securities |
Person’s votes |
|---|---|---|---|---|---|
| Nexsen Limited | Refer to Annexure B |
Refer to Annexure B |
Restrictions on the disposal of shares under mandatory escrow arrangements imposed by the Company in accordance with the ASX Listing Rules result in the Company having a technical relevant interest in its own shares that requires disclosure under section 671B of the Corporations Act 2001(Cth) (theAct) by virtue of section 671B(7)(c) of the Act. However, the Company has no rights of acquisition or voting over these shares and does not hold a relevant interest in these shares by virtue of section 609(9B) of the Act (other than for disclosure purposes under section 671B of the Act). |
107,430,104 FPO |
107,430,104 |
Further information is available in the Company’s Prospectus (released on ASX 10 October 2025) and Annexure A to this form provides a model of the restriction notices that have been issued.
5. Changes in association
The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows:
Name and ACN/ARSN (if applicable) Nature of association None. N/A Addresses The addresses of persons named in this form are as follows: Name Address Nexsen Limited Suite 1005, 4 Bridge Street, Sydney NSW 2000
6. Addresses
The addresses of persons named in this form are as follows:
Signature
print name SONNY DIDUGU capacity COMPANY SECRETARY, NEXSEN LIMITED sign here date 27 FEBRUARY 2026
DIRECTIONS
-
(1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the form.
-
(2) See the definition of "associate" in section 9 of the Corporations Act 2001.
-
(3) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.
-
(4) The voting shares of a company constitute one class unless divided into separate classes.
-
(5) The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.
-
(6) Include details of:
-
(a) any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and
(b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).
See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.
- (7) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, becom`e entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.
(8) If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write "unknown".
Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.
Annexure A – Restriction Notices Model
==> picture [534 x 755] intentionally omitted <==
==> picture [534 x 754] intentionally omitted <==
Annexure B – Listing of All Escrowed Holders
| SHAREHOLDER | SHARES SUBJECT TO ESCROW |
ESCROW PERIOD |
|---|---|---|
| FREDRONN PTY LTD | 150,000 | 24 months from quotation date |
| KAELIS FLINN BALL | 125,000 | 24 months from quotation date |
| RONNYMAX PTY LTD | 25,000 | 24 months from quotation date |
| RUTHIE PTY LTD | 100,000 | 24 months from quotation date |
| VIDOG CAPITAL PTY LTD | 1,000,000 | 24 months from quotation date |
| CAPITAL CORPORATION (HOLDINGS) | 931,700 | 24 months from quotation date |
| KIMBERLEY DAWN HANLY + THOMAS SYLVANUS HANLY HANLY FAMILY SUPERFUND> | 169,400 | 24 months from quotation date |
| AJAVA HOLDINGS PTY LTD | 3,998,000 | 24 months from quotation date |
| AJAVA HOLDINGS PTY LTD | 1,999,000 | 24 months from quotation date |
| APEX CONSULTING PROPRIETARY | 2,498,750 | 24 months from quotation date |
| APEX FUND SERVICES PTY LTD EMERGING\ COMPANIES> |
9,995,000 | 24 months from quotation date |
| CAPITAL CORPORATION (HOLDINGS) PTY LTD | 500,000 | 24 months from quotation date |
| KIMBERLEY DAWN HANLY + THOMAS SYLVANUS HANLY HANLY INVESTMENT TRUST> | 150,000 | 24 months from quotation date |
| KIMBERLEY DAWN HANLY + THOMAS SYLVANUS HANLY HANLY INVESTMENT TRUST> | 5,097,450 | 24 months from quotation date |
| MARK MUZZIN + CHRISTINA ANNE MUZZIN + TOMAS MUZZIN |
17,991,000 | 24 months from quotation date |
| MARK MUZZIN + CHRISTINA ANNE MUZZIN + TOMAS MUZZIN |
17,991,000 | 24 months from quotation date |
| MARK ANTHONY MUZZIN | 2 | 24 months from quotation date |
| MARK ANTHONY MUZZIN | 1,000,000 | 24 months from quotation date |
| MAVIX PTY LTD | 999,500 | 24 months from quotation date |
| MISHTALEM PTY LTD | 99,950 | 24 months from quotation date |
| EVELYNE JEAN TYMMS | 99,950 | 24 months from quotation date |
| MM&R SERVICES PTY LTD | 99,950 | 24 months from quotation date |
| MOSHE TUVYA AMZALAK | 199,900 | 24 months from quotation date |
| KRISTIE LAUREN HANNAH | 99,950 | 24 months from quotation date |
| NON CORRELATED CAPITAL PTY LTD | 1,999,000 | 24 months from quotation date |
| NON CORRELATED CAPITAL PTY LTD | 1,332,667 | 24 months from quotation date |
| PRIYANKA BHUSHAN GUPTA | 1,250,000 | 24 months from quotation date |
| PROVISION ADVISORY PROPRIETARY | 2,498,750 | 24 months from quotation date |
| RACHEL AMZALAK | 24,988 | 24 months from quotation date |
| RAJESH RAMANATHAN | 999,500 | 24 months from quotation date |
| RUTHIE PTY LTD | 774,613 | 24 months from quotation date |
| SCRATCHING AROUND 4 RETURNS PTY LTD A/C> | 999,500 | 24 months from quotation date |
| SEISMIC ENTERPRISES PTY LTD | 1,999,000 | 24 months from quotation date |
| SPARK PLUS PTE LTD | 499,750 | 24 months from quotation date |
| THOMAS WILLIAM WALKER | 99,950 | 24 months from quotation date |
| TOVA MIRIAM LEUCHTER | 199,900 | 24 months from quotation date |
| VIDOG CAPITAL PTY LTD | 2,598,700 | 24 months from quotation date |
|---|---|---|
| VIRUL CAPITAL PTY LTD | 666,334 | 24 months from quotation date |
| VORIAN INVESTMENT (HOLDINGS) PTY LTD INVESTMENT A/C> |
9,950,000 | 24 months from quotation date |
| ARACHCHIGE WEERANTHUNGE | 999,500 | 24 months from quotation date |
| WENDY PATRICIA FIGUEROA | 99,950 | 24 months from quotation date |
| WINSOME MARY SANTA MARIA | 9,995,000 | 24 months from quotation date |
| WINSOME MARY SANTA MARIA | 125,000 | 24 months from quotation date |
| OSCHIE CAPITAL PTY LIMITED | 4,997,500 | 24 months from quotation date |